ASR Guidance Development May Be Supported By AdvaMed FAQ Document
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed plans to revise a set of frequently asked questions related to analyte specific reagents that could be used as a starting point for an FDA guidance document, following a recent meeting with the agency
You may also be interested in...
AdvaMed Reworks ASR Language In Hopes Of Influencing New FDA Guidance
AdvaMed currently is gathering information, including legal opinions, on how current analyte specific reagent regulations could be altered
AdvaMed Reworks ASR Language In Hopes Of Influencing New FDA Guidance
AdvaMed currently is gathering information, including legal opinions, on how current analyte specific reagent regulations could be altered
DTC Genetic Testing Debated As Public Obtains Broader Access To Kits
DNA Direct - a company that sells genetic tests directly to consumers and provides counseling and interpretation of the results - plans to launch a panel of infertility assays in May